| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 25 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005783 | endoplasmic reticulum | 5 | 1 |
| GO:0005794 | Golgi apparatus | 5 | 1 |
| GO:0031982 | vesicle | 4 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AX22
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0002020 | protease binding | 4 | 1 |
| GO:0005488 | binding | 1 | 1 |
| GO:0005515 | protein binding | 2 | 1 |
| GO:0019899 | enzyme binding | 3 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.537 |
| CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.355 |
| CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.229 |
| CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.229 |
| CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.520 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.430 |
| DEG_SCF_FBW7_1 | 60 | 65 | PF00400 | 0.229 |
| DOC_MAPK_gen_1 | 81 | 90 | PF00069 | 0.393 |
| DOC_MAPK_MEF2A_6 | 105 | 112 | PF00069 | 0.373 |
| DOC_MAPK_NFAT4_5 | 105 | 113 | PF00069 | 0.362 |
| DOC_MAPK_RevD_3 | 68 | 82 | PF00069 | 0.229 |
| DOC_PP1_RVXF_1 | 36 | 42 | PF00149 | 0.289 |
| DOC_USP7_MATH_1 | 60 | 64 | PF00917 | 0.326 |
| DOC_USP7_UBL2_3 | 8 | 12 | PF12436 | 0.528 |
| DOC_WW_Pin1_4 | 56 | 61 | PF00397 | 0.405 |
| DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.353 |
| LIG_14-3-3_CanoR_1 | 105 | 109 | PF00244 | 0.429 |
| LIG_14-3-3_CanoR_1 | 83 | 89 | PF00244 | 0.325 |
| LIG_FHA_1 | 105 | 111 | PF00498 | 0.375 |
| LIG_FHA_1 | 19 | 25 | PF00498 | 0.423 |
| LIG_FHA_1 | 63 | 69 | PF00498 | 0.371 |
| LIG_FHA_1 | 85 | 91 | PF00498 | 0.430 |
| LIG_LIR_Apic_2 | 89 | 95 | PF02991 | 0.291 |
| LIG_LIR_Nem_3 | 93 | 99 | PF02991 | 0.344 |
| LIG_SH2_CRK | 92 | 96 | PF00017 | 0.429 |
| LIG_SH2_NCK_1 | 92 | 96 | PF00017 | 0.377 |
| LIG_SH2_PTP2 | 74 | 77 | PF00017 | 0.229 |
| LIG_SH2_STAP1 | 106 | 110 | PF00017 | 0.362 |
| LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.362 |
| LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.394 |
| LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.362 |
| LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.277 |
| LIG_SUMO_SIM_anti_2 | 48 | 56 | PF11976 | 0.301 |
| LIG_SUMO_SIM_anti_2 | 87 | 93 | PF11976 | 0.307 |
| LIG_SUMO_SIM_par_1 | 3 | 9 | PF11976 | 0.585 |
| LIG_UBA3_1 | 1 | 8 | PF00899 | 0.368 |
| MOD_GSK3_1 | 56 | 63 | PF00069 | 0.430 |
| MOD_NEK2_1 | 90 | 95 | PF00069 | 0.363 |
| MOD_PKA_2 | 104 | 110 | PF00069 | 0.429 |
| MOD_Plk_2-3 | 45 | 51 | PF00069 | 0.410 |
| MOD_ProDKin_1 | 56 | 62 | PF00069 | 0.405 |
| MOD_SUMO_for_1 | 99 | 102 | PF00179 | 0.301 |
| TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.362 |
| TRG_ER_diArg_1 | 80 | 83 | PF00400 | 0.229 |
| TRG_NLS_MonoExtN_4 | 79 | 85 | PF00514 | 0.229 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HSR0 | Leptomonas seymouri | 48% | 100% |
| A0A1X0NX79 | Trypanosomatidae | 31% | 98% |
| A0A3Q8IC64 | Leishmania donovani | 75% | 97% |
| A0A3R7MAP9 | Trypanosoma rangeli | 34% | 100% |
| A4HDN8 | Leishmania braziliensis | 55% | 100% |
| C9ZWC6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 93% |
| E9AH84 | Leishmania infantum | 75% | 97% |
| Q868G9 | Leishmania major | 67% | 100% |
| Q966X9 | Trypanosoma cruzi | 34% | 100% |